SEC Form 4 · accession 0001125345-18-000109
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Blasius Risser
Officer — Sr VP & Chief Business Officer
Period of report
Dec 12, 2018
Accepted (ET)
Dec 13, 2018 · 4:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 12, 2018 | M | 5,000 | $0.94 | A | 22,309 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) | $0.94 | Dec 12, 2018 | M | 5,000 | D | Sep 24, 2009 | Mar 23, 2019 | Common Stock | 5,000 | 4,497 | D |
Explanation of responses
- F1This includes 792 shares acquired under the MacroGenics, Inc. Employee Stock Purchase Plan (ESPP) on May 31, 2018, and 417 shares acquired under the ESPP on November 30, 2018.
- F2The transaction represents an exercise and hold of expiring options.